Gabapentin Capsule
Product Images NDC 72162-1534

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day groups. The x-axis shows weeks from baseline to 8, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain scores over 7 weeks during a 3-week dose titration and a 4-week fixed dose period. It compares three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day, plotted against time in weeks.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing two studies. Study 1 compares placebo (12%) to Gabapentin 3600 mg (29%) responders. Study 2 compares placebo (14%) to Gabapentin 1800 mg (32%) and 2400 mg (34%) responders. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

An illustration showing the formula to calculate creatinine clearance (CLCr). The formula factors in age in years, weight in kilograms, serum creatinine in mg/dL, and includes a multiplication adjustment of 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin illustrating its molecular arrangement with a cyclohexane ring and amino and carboxyl functional groups. The diagram shows the bonded atoms and the overall shape representative of the active ingredient Gabapentin.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart depicting differences in percentage on the y-axis versus daily dose in milligrams on the x-axis. The chart compares results across three studies labeled as study a, study b, and study c, each represented by different colored squares, showing data points at daily doses from 600 mg to 1800 mg.*

FDA Label Image

Label (Lbl721621534)

Label for Gabapentin Capsules USP, 400 mg strength, in a package of 100 capsules. The label shows the product NDC 72162-1534-1 and indicates the capsules are relabeled by Bryant Ranch Prepack, Inc., with manufacturing by ScieGen Pharmaceuticals, Inc. Storage instructions and a pharmacist note to dispense patient guides are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.